Delfi Diagnostics is focused on detecting and locating early cancer through blood testing. Cell-free DNA breaks into fragments in the bloodstream and carries many clues about whether a person may have early-stage cancer. Delfi applies advanced machine-learning methods to accurately detect cancer from these fragments and also determine where in the body the tumor has grown. Delfi Diagnostics is located in Baltimore and was founded by leading researchers at Johns Hopkins University.